Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022
Journal of Drugs in Dermatology · 01.03.2023 · 22 (3) · 310-311
DOI: 10.36849/jdd.7087 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.02.2023. Verfasst von Jennifer Jacobs und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Seborrheic, Keloid. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Jacobs, J., Lebhar, J., Diamond, C., Rundle, C., & Stamey, C. (2023). Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022. Journal of Drugs in Dermatology, 22(3), 310-311. https://doi.org/10.36849/jdd.7087
Vancouver
Jacobs J, Lebhar J, Diamond C, Rundle C, Stamey C. Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022. Journal of Drugs in Dermatology. 2023;22(3):310-311. doi:10.36849/jdd.7087
BibTeX
@article{Jacobs2023,
author = {Jacobs, Jennifer and Lebhar, Jamie and Diamond, Carrie and Rundle, Chandler and Stamey, Christopher},
title = {Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022},
journal = {Journal of Drugs in Dermatology},
year = {2023},
volume = {22},
number = {3},
pages = {310--311},
doi = {10.36849/jdd.7087}
}
EUVIMED